Ameridose, a drug manufacturer based in Massachusetts, recently recalled all of its products after failing an FDA sterility test. It is managed by some of the same individuals as the New England Compounding Center, which was recently associated with the fungal meningitis outbreak. Closed by the Massachusetts Board of Registration on October 10, the Ameridose facility will remain shuttered at least through the end of November. The company is a major supplier of sterile injectable medications to hospitals across the country and this recall willescalate the existing critical drug shortage problem. According to the FDA, six of those recalled products were already on its critical shortage list even before the recall. Sodium Bicarbonate, a drug essential to many healthcare functions and often described as being in stock “in every unit on every floor of every hospital,” is in danger of disappearing completely from some hospitals because Ameridose was one of the only four companies producing it.
Continue reading here
No comments:
Post a Comment